Seae Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
KIYATEC develops 3D Predict, a tumor-specific testing platform that uses patient-derived tumor cells to predict how individual cancers respond to therapies.
BiotechDigital HealthHealthtechMedical DevicesGreenville, US
Matthew Gevaert(Director)Eric Perreault(Executive Officer, Director)inMelissa Rayner(Executive Officer)Scott Isacksen(Executive Officer)Bob Silverman(Director)H. Lee Higdon III(Director)
Board seatJason Robart· per SEC Form D
Co-investorsAtlanta Technology Angels
Movn Health is a healthcare company focused on improving access to cardiovascular care, working to improve health outcomes, care coordination, patient engagement, and retention.
Digital HealthHealthtechLos Angeles, US
Harshvardhan Vathsangam(Executive Officer, Director)Ade Adesanya(Director)in
BoardBob Saunders(Director)John Kim(Director)Eric Marton(Director)inAdrian James(Director)
Board seatJason Robart· per SEC Form D
Co-investorsAphelion CapitalFoothill VenturesSolve VenturesSteelSky VenturesCiti VenturesNueterra Capital+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.